Phospholipid derivatives, and pharmaceutical composition of the same
US4562179A · kind A · utility
22Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 1983 |
| Grant date | Dec 31, 1985 |
| Priority date | — |
| Expiry date | Apr 6, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/4075
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
New phospholipid derivatives represented by the formula: ##STR1## wherein R.sup.1 is alkyl, alkoxy or alkanoylamino; PA0 R.sup.2 is lower alkyl, lower alkanesulfonyl or arenesulfonyl; PA0 R.sup.3, R.sup.4 and R.sup.5 are each lower alkyl; PA0 n is 0 or 1 PA0 A is lower alkylene optionally interrupted by a --NHCO-- group; and PA0 Q is oxido or lower alkoxy; provided that n is 0 or A is lower alkylene interrupted by a --NHCO-- group, or Q is lower alkoxy, when R.sup.1 is alkoxy and R.sup.2 is lower alkyl; and pharmaceutically acceptable salts thereof, which exhibit antitumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.